
医学资讯ACKR3CXCR7
靶向 ACKR3/CXCR7:增强血小板抗凝脂质并调控促凝功能,为血栓管理提供新思路
By MedXY|2026年9月18日
药理性激活 CXCR7 可调节血小板脂质代谢、维持线粒体功能并降低促凝活性,为降低心血管疾病血栓风险提供了新的治疗策略。
Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.
You can change your choice at any time.